| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.6M | -42.5% |
| SG&A Expense | $3.7M | -14.2% |
| Operating Income | -$7.4M | +31.8% |
| Income Tax | $0 | — |
| Net Income | -$7.2M | +34.0% |
| EPS (Basic) | -$9.08 | -74.6% |
| EPS (Diluted) | -$9.08 | -74.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | -36.6% |
| Current Assets | $5.7M | -38.5% |
| Total Assets | $5.7M | -38.7% |
| Current Liabilities | $1.0M | -37.9% |
| Total Liabilities | $1.0M | -37.9% |
| Stockholders' Equity | $4.7M | -38.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | +33.8% |
| Capital Expenditures | $1K | -80.0% |
| Investing Cash Flow | $8K | +260.0% |
| Financing Cash Flow | $4.0M | -46.1% |
| Free Cash Flow | -$7.1M | +33.9% |